Emerald Clinical

08/04/2026

🔴 LIVE WEBINAR

Are we entering a new era in rare kidney disease?

Recent advances in nephrology are driving a “Glomerular Revolution”—reshaping how conditions like IgA nephropathy, FSGS, and C3 glomerulopathy are diagnosed and treated.

Join our upcoming webinar to explore:
🔹 The role of biomarkers and early diagnosis
🔹 Shared disease pathways across rare kidney conditions
🔹 Breakthrough therapies—and what’s next
🔹 How smarter trial design and ex*****on can accelerate new treatments

Don’t miss this opportunity to gain practical insights into improving decision-making and advancing patient outcomes.

👉 Register now: https://bit.ly/4rCGlpA

06/04/2026

WCN Japan Done – We’re Ready for What’s Next

A highlight for us was connecting with so many of you—industry leaders and researchers, who are as passionate about advancing clinical development as we are. A special thank you to our Scientific Leadership Team for stopping by our booth; it was a pleasure to meet in person.

As a global CRO with deep expertise in renal, conversations like these remind us why we do what we do. If we didn’t have the chance to connect during the conference, we’d still love to hear from you—reach out anytime. https://bit.ly/4r8ELvG

See you at the next one.

27/03/2026

Join our live webinar!

Recent advances in nephrology are driving a “Glomerular Revolution,” reshaping the management of rare kidney diseases.
This webinar explores key conditions including IgAN, PMN, FSGS and C3G, with a focus on shared pathophysiology, early diagnosis, biomarker use and diagnostic challenges.

Claudio Hegenberger and Jonathan Barrett will also discuss emerging therapies and why continued research—particularly combination approaches—offers new hope for improved patient outcomes.

Secure your place to learn how biomarker-informed strategies and trial ex*****on choices can improve decision-making in rare kidney disease. https://bit.ly/4rCGlpA

Research Development Diagnosis , Diseases/Orphan Drugs

26/03/2026

Two days to go!

Meet the World Leader in Renal Research at WCN 2026 #38

Connect with Peyni Chan (Head of China and Global Partnerships) and Jen Wong (Director, Scientific and Medical Affairs). Learn how to make smarter, faster, and more patient-centered decisions with their guidance.

Book a meeting with us: https://emeraldclinical.com/meet-us-at-the-world-of-congress-nephrology-2026/ -form

Curious how we’ve done it before? Check out our case studies here:

-Recruitment Success in Large IgAN Trial Highlights Value of Scientific Leadership

https://emeraldclinical.com/insights/resources/recruitment-success-in-large-igan-trial-highlights-value-of-scientific-leadership/)

-Emerald Clinical Brings Robust Retention Strategy and Tactics to Global Rare Renal Disease Studies

https://emeraldclinical.com/insights/resources/emerald-clinical-brings-robust-retention-strategy-and-tactics-to-global-rare-renal-disease-studies/)

See you in Yokohama!

25/03/2026

Proud moment as we win:
Asia Pacific Biopharma Excellence Awards 2026
Best Clinical Trials Supplier Award for Patient Recruitment & Engagement

“It was a great honour to represent Emerald Clinical Trials at the Asia Pacific Biopharma Excellence Awards 2026 in Singapore and accept the Best Clinical Trials Supplier Award for Patient Recruitment & Engagement. This recognition is a testament to the hard work, dedication, and talent of our project teams, who are committed to improving patient engagement and accelerating clinical development. Our continued focus on patient-centric recruitment and engagement helps advance clinical research and bring innovative therapies closer to the patients who need them.”
— Kuldeep Patil, PhD, Senior Director, Project Delivery, Emerald Clinical Trials

Read the full story - https://bit.ly/3ORiC7A

24/03/2026

There’s still time to connect with David Cass at BIO-Europe!

If you’re attending, don’t miss the opportunity to meet with David and learn how Emerald Clinical can support your clinical trial goals with flexible, science-led solutions.

Can’t make it? Visit emeraldclinical.com to learn more about how we can help advance your programs.

Let’s start the conversation—see you there.

24/03/2026

Release the full commercial potential of your program with expert guidance from top-tier renal experts.

Identify potential obstacles and opportunities, aligning your clinical design with current standards of care, patient needs, and regulatory expectations.

We’ll ensure a sound strategy with nuanced perspectives on trial feasibility, endpoint selection, and emerging biomarkers.

Reduce risk and enhance your potential for success.​

Find out more about our Renal Advisory Board https://bit.ly/3JEmrun

23/03/2026

Join Our Team!

At Emerald Clinical, we’re a global CRO dedicated to advancing research in renal, oncology, cardiovascular, autoimmune, and other critical therapeutic areas. Our teams work together across regions to support the development of therapies that can improve and extend lives worldwide.

We’re continuously opening new opportunities in our offices around the globe. If you’re looking for a place where you can grow your career while contributing to research that truly makes a difference for patients, we’d love to hear from you.

Find your next opportunity and join us in advancing therapies that improve lives for all. https://careers.emeraldclinical.com/

21/03/2026

One Week to Go! Meet the Emerald Team at WCN 2026

We are just one week away from the World Congress of Nephrology 2026 in Yokohama.

If you are heading to the congress, we warmly invite you to stop by the Emerald Booth #38, where Peyni Chan, Head of China and Global Partnership, and Jen Wong, Director of Scientific and Medical Affairs, will be waiting to connect with you. It's always a highlight to share insights and explore how we can shape the future of renal development together.

With leadership in renal science, we deliver complex trials that generate strong evidence to improve care and make a meaningful difference for people living with kidney disease.

Let’s make time for a real conversation: Meet us at the World of Congress Nephrology 2026 - https://bit.ly/4bbcuyi

See you next week in Yokohama!

20/03/2026

Emerald Clinical’s Emily Todd and Kevin Ketchum are excited to attend American College of Cardiology March 28 in New Orleans, LA.

Emerald Clinical combines scientific leadership with global operational power to deliver cardiometabolic trials that impact practice and policy worldwide.

Whether you are in early-phase discovery or post-marketing surveillance, our experts provide the actionable insights needed for success.

🔗 Let’s drive real change. https://emeraldclinical.com/therapeutic-expertise/cardiovascular-cro/

Explore our specialized CRO solutions today.

19/03/2026

ABEA2026: Exclusive Interview with Mr Kuldeep Patil, Senior Director , Project Delivery, Emerald Clinical Trials

Check out this interview with Kuldeep Patil, Senior Director, Project Delivery, and Crystal Xu, Senior Project Manager . They reflect on winning Best Clinical Trials Supplier Award: Patient Recruitment & Engagement at the Asia-Pacific Biopharma Excellence Awards, held on 11 March in Singapore. https://bit.ly/4bLY0q9

Read more: ABEA2026: Exclusive Interview with Mr Kuldeep Patil, Senior Director , Project Delivery, Emerald Clinical Trials

19/03/2026

World Kidney Day may have been a week ago, but at Emerald Clinical—the expert renal CRO—our teams support kidney research to improve the lives of patients worldwide every day.

Our Sydney team recently came together to mark the occasion with a group walk, followed by a celebration back at the office. It was a great moment to connect as a team and reflect on the importance of advancing renal research for patients around the globe.

Learn more about how we partner with organizations to improve lives worldwide: [https://bit.ly/4qDFjdf](https://bit.ly/4qDFjdf)